Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides

Gene Therapy

Volumn 5, Issue 7, 1998, Pages 955-964

  Simoes S ^a,b,c   Slepushkin, V ^a   Caspar, R ^b,d   Pedroso de Lima, M C ^c,d   Duzgunes N ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Cationic liposomes; Fusigenic peptides; Gene delivery; Transferrin

Indexed keywords

ANION; BETA GALACTOSIDASE; CATION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; GALAPTIN; HEMAGGLUTININ; LIPOSOME; LUCIFERASE; TRANSFERRIN; TRIMETHYLAMMONIUM SALT DERIVATIVE;

ARTICLE; DNA PROTEIN COMPLEX; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; ZETA POTENTIAL;

EID: 0031825183     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300674     Document Type: Article

References (62)

1. Tolstoshev P. Gene therapy, concepts, current trials and future directions. Annu Rev Pharmacol Toxicol 1993; 33: 573-596.
2. Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993; 62: 191-217.
3. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
4. Wolff JA (ed). Gene Therapeutics. Birkhäuser: Boston, 1994.
5. Blau HM. Gene therapy - a novel form of drug delivery. New Engl J Med 1995; 333: 1204-1207.
6. Treco DA, Selden RF. Non-viral gene therapy. Mol Med Today 1995; 1: 314-321.
7. Felgner PL et al. Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci 1995; 772: 126-139.
8. Reifers F, Kreuzer J. Current aspects of gene therapy: implications for vascular interventions. J Mol Med 1995; 73: 595-602.
9. Taneja SS, Pang S, Cohan P, Belldegrun A. Gene therapy: principles and potential. Cancer Surv 1997; 23: 247-266.
10. Anderson WF. Gene therapy. Sci Am 1995; 273: 96-98.
11. Marshall E. Gene therapy's growing pains. Science 1995; 269: 1050-1055.
12. Marshall E. Less hype, more biology needed for gene therapy. Science 1995; 270: 1751.
13. Crystal R. Transfer of genes into humans: early lessons and obstacles to success. Science 1995; 270: 404-410.
14. Singhal A, Huang L. Gene transfer in mammalian cells using liposomes as carriers. In: Wolf JA (ed). Gene Therapeutics: Methods and Applications of Direct Gene Transfer. Birkhauser: Boston, 1994, pp 118-142.
15. Lee RJ, Huang L. Folare-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481-8487.
16. Hug P, Sleight RG. Liposomes for the transformation of eukaryotic cells. Biochim Biophys Acta 1991; 1097: 1-17.
17. Lasic DD, Templeton NS. Liposomes in gene therapy. Adv Drug Deliv Rev 1996; 20: 221-266.
18. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285-1288.
19. Philip R et al. In vivo gene delivery: efficient transfection of T lymphocytes in adult mice. J Biol Chem 1993; 268: 16087-16090.
20. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
21. Liu Y et al. Cationic liposome-mediated intravenous gene delivery. J Biol Chem 1995; 270: 24864-24870.
22. Thierry AR et al. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci USA 1995; 92: 9742-9746
23. Takehara T et al. Expression of the hepatitis C virus genome in rat liver after cationic liposome-mediated in vivo gene transfer. Hepatology 1995; 21: 746-751.
24. Remy J-S et al. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci USA 1995; 92: 1744-1748.
25. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
26. Konopka K, Pretzer E, Felgner PL, Düzgüneş N. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochim Biophys Acta 1996; 1312: 186-196.
27. Konopka K, Harrison GS, Felgner PL, Düzgüneş N. Cationic liposome-mediated expression of HFV-regulated luciferase and diphtheria toxin A genes in HeLa cells infected with or expressing HIV. Biochim Biophys Acta 1997; 1356: 185-197.
28. Felgner PL et al. Editorial: nomenclature for synthetic gene delivery systems. Hum Gene Ther 1997; 8: 511-512.
29. Friend DS, Debs RJ, Düzgüneş N. Interaction between DOTMA liposomes, CV1 and U937 cells, and their isolated nuclei. J Cell Biol 1990; 111: 119a (Abstr.).
30. Friend DS, Papahadjopoulos D, Debs RJ. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta 1996; 1278: 41-50.
31. Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta 1994; 1189: 195-203.
32. Wrobel I, Collins D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta 1995; 1235: 296-304.
33. Subbarao NK et al. pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry 1987; 26: 2964-2972.
34. Parente RA, Nir S, Szoka FC Jr. pH-dependent fusion of phosphatidylcholine small vesicles. J Biol Chem 1988; 263: 4724-4730.
35. Wagner E et al. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 1992; 89: 7934-7938.
36. Düzgüneş N, Shavnin SA. Membrane destabilization by N-terminal peptides of viral envelope proteins. J Mem Biol 1992; 128: 71-80.
37. Plank C et al. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 1994; 269: 12918-12924.
38. Simões S et al. Enhancement of cationic liposome-mediated gene delivery by transferrin and fusogenic peptides. 24th Intl Symp Control Rel Bioact Mat, Stockholm 1997 (Abstr.).
39. Düzgüneş N et al. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusogenic peptides. Conf Artif Self-Assembling Syst Gene Del, Coronado, CA, 1997 (Abstr.).
40. Wagner E et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990; 87: 3410-3414.
41. Erbacher P et al. Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum Gene Ther 1996; 7: 721-729.
42. Cheng PW. Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther 1996; 7: 275-282.
43. Gershon H, Ghirlando R, Guttman SB, Minsky A. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry 1993; 32: 7143-7151
44. Legendre J-Y, Szoka FC Jr. Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells. Proc Natl Acad Sci USA 1993; 90: 893-897.
45. Felgner JH et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550-2561.
46. Düzgüneş N, Wilschut J, Fraley R, Papahadjopoulos D. Studies on the mechanism of membrane fusion: role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. Biochim Biophys Acta 1981; 642: 182-195.
47. Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acts 1995; 1235: 289-295.
48. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells. Proc Natl Acad Sci USA 1988; 85: 7972-7976.
49. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 1991; 266: 17707-17712.
50. Kicher A, Mechtler K, Behr J-P, Wagner E. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconj Chem 1997; 8: 213-221.
51. Felgner PL et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7417.
52. Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated UNA transfection. Proc Natl Acad Sci USA 1989; 86: 6077-6081.
53. Ciccarone V, Hawley-Nelson P, Jessee J. Cationic liposome-mediated transfection: effect of serum on expression and efficiency. Focus 1993; 15: 80-83.
54. Li S, Huang L. Lipidic supramolecular assemblies for gene transfer. J Liposome Res 1996; 6: 589-608.
55. Cotten M, Wagner E, Bimstiel ML. Receptor-mediated transport of DNA into eukaryoric cells. Meth Enzymol 1993; 217: 618-644.
56. Kamata H, Yagisawa H, Takahashi S, Hirata H. Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection. Nucleic Acids Res 1994; 22: 536-537.
57. Parente RA, Nir S, Szoka FC Jr. Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry 1990; 29: 8720-8728.
58. Fattal E, Nir S, Parente RA, Szoka FC Jr. Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry 1994; 33: 6721-6731.
59. Simões S et al. Transfection of human monocyte-derived macrophages by transferrin-cationic Iipid-DNA complexes. FASEB J 1997; 11: A1090.
60. Kircheis R et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Therapy 1997; 4: 409-418.
61. Mechtler K, Wagner E. Gene transfer mediated by influenza virus peptides: the role of peptide sequences. New J Chem 1997; 21: 105-111.
62. Fields RD, Lancaster MV. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotech Lab 1993; 11: 48-50.